Dental Caries Class IINCT04888676
Clinical Evaluation of Self- Adhesive Bulk-fill Resin Composite Versus Conventionally Bonded Bulk-fill Resin Composite in Restoration of Proximal Lesions
A study testing Class II Restoration in people with Dental Caries Class II, run by Cairo University at 1 site in Egypt.
Trial summary
This study will be conducted to evaluate and compare the clinical performance of Self- Adhesive Bulk fill Resin Composite Versus Conventionally Bonded Bulk fill resin composite in Restoration of Proximal Lesions Over a Period of 18 months Follow-up Examination and selection of all patients will be done according to… Read more about this study
- Who is it for?
- Ages 18 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Dental Caries Class II
- What is being tested?
- Class II Restoration
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Jun 2021to 15 May 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- -
- Patient-related criteria:
- Patients consulting in one of the outpatient clinics listed above.
- Able to tolerate necessary restorative procedures.
- Provide informed consent.
- Accepts the 18 months follow-up period.
Show all 9Show fewer
- Tooth related criteria:
- Teeth with primary proximal carious lesions .
- Teeth are vital according to pulp-sensitivity tests.
Who cannot join
- Patient-related criteria:
- Medically compromised patients, as they will not be able to attend multiple appointments or may require special management.
- Pregnant women; as radiographs cannot be taken for them.
- Allergy to any of the restorative materials, including anesthetics.
- Uncooperative patients, will not abide by the instructions or attend the appointments.
- Tooth related criteria:
Show all 12Show fewer
- Deciduous teeth; as the study is targeting only permanent teeth.
- Teeth with previous restorations, which may add another variable to the study (type of old restorative material, extent of recurrent caries).
- Spontaneous pain or prolonged pain after sensitivity tests (cold and electrical tests), which would indicate irreversible pulpal damage.
- Negative sensitivity tests, periapical radiolucencies and sensitivity to axial or lateral percussion, which would indicate pulp necrosis.
- Teeth presenting external or internal resorption, with adverse pulpal reactions which may affect the outcome of the study.
- Teeth with cervical caries; which can't be evaluated on periapical radiographs.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Clinical Evaluation of Self- Adhesive Bulk-fill Resin Composite Versus Conventionally Bonded Bulk-fill Resin Composite in Restoration of Proximal Lesions Over a Period of 18 Months Follow-up: A Randomized Clinical Trial
This study will be conducted to evaluate and compare the clinical performance of Self- Adhesive Bulk fill Resin Composite Versus Conventionally Bonded Bulk fill resin composite in Restoration of Proximal Lesions Over a Period of 18 months Follow-up
Examination and selection of all patients will be done according to inclusion and exclusion criteria.A Class II cavity will be prepared after local anesthesia has been given as required. Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence,. For the intervention: The sectional matrix will be applied first , followed by filling of cavity with Advanced Self- Adhesive bulk-fill Resin Composite. (Surefil one™ ,Dentsupply Sirona) in increments of 3-4mm,For the control group:
The sectional matrix will be applied first , followed by filling of cavity with bulk-fill resin composite material (GrandioSO x-tra® bulk) in increments of 3-4mm,Clinical evaluation will be done using using USPHS criteria at 6,12 and 18 months follow up.
Read the detailed description
- Participants, interventions \& outcomes 9. Study setting Study will be conducted in the Conservative Dentistry Department, Faculty of Dentistry - Cairo University.
- Eligibility criteria 10.a.1 Inclusion criteria:
Patient-related criteria:
- Patients consulting in one of the outpatient clinics listed above.
- Able to tolerate necessary restorative procedures.
- Provide informed consent.
- Accepts the 18 months follow-up period.
Tooth related criteria:
- Teeth with primary proximal carious lesions .
- Teeth are vital according to pulp-sensitivity tests. 10.a.2 Exclusion criteria
Patient-related criteria:
- Medically compromised patients, as they will not be able to attend multiple appointments or may require special management.
- Pregnant women; as radiographs cannot be taken for them.
- Allergy to any of the restorative materials, including anesthetics.
- Uncooperative patients, will not abide by the instructions or attend the appointments.
Tooth related criteria:
- Deciduous teeth; as the study is targeting only permanent teeth.
- Teeth with previous restorations, which may add another variable to the study (type of old restorative material, extent of recurrent caries).
- Spontaneous pain or prolonged pain after sensitivity tests (cold and electrical tests), which would indicate irreversible pulpal damage.
- Negative sensitivity tests, periapical radiolucencies and sensitivity to axial or lateral percussion, which would indicate pulp necrosis.
- Teeth presenting external or internal resorption, with adverse pulpal reactions which may affect the outcome of the study.
- Teeth with cervical caries; which can't be evaluated on periapical radiographs. 11. Interventions 11.a. Examination and diagnosis: Examination and selection of all patients will be done according to inclusion and exclusion criteria. Diagnosis of patients' chief complaint and teeth that will be involved in this study will be done. Teeth are to be chosen according to standardized radiographic examination. Teeth should have proximal, primary carious lesions . 11.b. Cavity preparation procedure: A Class II cavity will be prepared after local anesthesia has been given as required. The cavity will be prepared using a high-speed hand-piece with air and water coolant and diamond burs of different sizes. Sharp excavators will allow accessible removal of soft carious lesions will be used. Any tooth that will suffer from pulpal exposure will be excluded from the study. Finishing of the cavity walls will be done using a fine-grit, yellow coded, diamond bur. 11.c. Isolation: Rubber dam isolation will be done. 11.d. Matricing and wedging: Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence. 11.e. For the intervention: The sectional matrix will be applied first , followed by filling of cavity with Advanced Self- Adhesive bulk-fill Resin Composite. (Surefil one™ ,Dentsupply Sirona) in increments of 3-4mm, as required to end up with leaving an occlusal space on top of at least 2mm. Finally finishing and occlusal adjustment will be done under water spray by using superfine diamond burs. Polishing will be done using pre-impregnated rubber cups. Materials will be manipulated according to manufacturer instructions. 11.f. For the control group: The sectional matrix will be applied first , followed by filling of cavity with bulk-fill resin composite material (GrandioSO x-tra® bulk) in increments of 3-4mm, as required to end up with leaving an occlusal space on top of at least 2mm. Finally finishing and occlusal adjustment will be done under water spray by using superfine diamond burs. Polishing will be done using pre-impregnated rubber cups. Materials will be manipulated according to manufacturer instructions. 11.g. Intervention modification: Restoration will be removed when there are any signs of leakage, fracture or severe post-operative pain due to pulpal response. 11.h. Intervention adherence: The patients' understanding of their conditions and treatments, and the amount of information given to the patient is positively related to adherence to the study and instructions given. Thus, the operator (M.S.) will inform the participants about all steps from the beginning to the end and explain the importance of restoring their teeth with such esthetic restorative materials, following instructions, attending follow up visits and how to maintain good oral hygiene. This will be done using simple oral conversation, emphasized by written and illustrated material whenever possible. Oral hygiene of the participants will be enhanced before intervention and any other chief and subsidiary complaint will be managed in order to modify their behavior.
- Outcomes: Clinical evaluation using USPHS criteria. 14. Sample Size : We are planning a study of independent cases and controls. Sample size was calculated based on the previous study by Guney et al in 2020. Prior data indicated that the probability of score A for marginal adaptation for bulk fill composite was 0.861 and score B was 0.139 with effect size w 0.722 (n=16). If the estimated probability of score A for marginal adaptation for self adhesive restorative material is 0.85 and score B is 0.15 with effect size w 0.7 (n=17), we will need to study a total of 33 restorations to be able to reject the null hypothesis that the success rates for case and controls are equal with probability (power) 0.8. This was increased to 40 subjects, 20 in each group to compensate for losses during follow up. The type I error probability associated with this test of this null hypothesis is 0.05. Sample size was calculated using G*Power version 3.1.9.2 for windows using chi-square test 15. Recruitment: Patients will be recruited by the principle investigator (M.S.) from outpatient clinic of conservative dentistry department in Faculty of Dentistry, Cairo University; from which eligible patients will be recruited to fulfill the eligibility criteria according to participant timeline.
- Assignment of interventions 16. Allocation - sequence generation 16.a. Random sequence generation (Randomization): Simple randomization will be assigned for participants by generating numbers from 1:48 using Random Sequence Generator, Randomness and Integrity Services Ltd (https://www.random.org/) by D.K. . Each generated random number will represent assigning both intervention and comparator to each patient in a random manner.
16.b. Allocation concealment mechanism: The restorative technique will be selected according to randomized numbers in a sealed envelope.
16.c. Implementation: Randomization will be performed by D.K. 17. Blinding Double Blinded; The participants Participants will be blinded to the technique used, since the patient will attend the same number of visits and he can not differentiate between different restorative materials.
Blinding of the operator The operator cannot be blinded because of the use of different restorative materials applied in each group.
The outcome assessor The outcome assessor will be blinded to the material used. This will be performed by M.A. and Y.H. Therefore it is necessary that the assessors won't be included in the preclinical assessment.
- Data collection, management and analysis 18. Data collection methods 18.a. Data collection methods: 18.a.i. Baseline data collection: For every patient, medical and dental history will be taken. Examination charts will be filled by M.S.
18.a.ii. Outcome data collection: Modified USPHS criteria for dental restoration will be evaluated by two assessors (M.A \& Y.H) at baseline, after 6 ,12 and 18 months, if both assessors differ in score, they will discuss the outcome, if they did not agree, a third assessor (D.M) will resolve the conflict. To achieve inter-examiners reliability, at the beginning of the study, the assessors will perform a profound assessment training program by performing repeated assessments of 36 proximal surface restorations using modified USHPS criteria. The main supervisor (O.S.) will supervise the training program to ensure that the assessors (M.A \& Y.H.) will be calibrated before starting their evaluation.
18.b. Patient retention: A record of patient's phone number will be included in every patient's chart. Phone call will be diverted to each patient in order to remind him/her for the time of his/her visit (M.S.). If the patient did not reply for any reason, another visit will be scheduled within a week.
- Data management: Data entry will be carried out by M.S. and revised by D.M. . All data will be stored on computer and will be encrypted using a password. This will be done to allow accurate data entry through revision and protect data from being incorrectly used. Data will be backed up on another storage device to prevent it from being lost.
- Statistical methods: Data will be analyzed using IBM SPSS advanced statistics (Statistical Package for Social Sciences), version 25 (SPSS Inc., Chicago, IL).Categorical data will be described as absolute risk for each intervention independently and relative risk when comparing both interventions. Comparisons between categorical variables will be performed using the chi square test. A p-value less than or equal to 0.05 will be considered statistically significant and all tests will be two tailed. Statistical power of the study will be set at 80 % with 95 % confidence level.
- Data monitoring:
- Monitoring: The main supervisor (O.S.) will monitor this study. Her role is to monitor any risk of bias could be done from participants, operator or assessors. Also to monitor blinding of the assessors and patient safety, outstanding benefits or harms.
- Harms: The principle investigator (M.S.) should inform participants about the possible harms (pain, loss of restoration, leakage and fracture of restorations) if present. Participants are allowed to contact the operator at moment through telephone. For assessment radiograph, inspection, percussion and sensitivity tests will be performed. The data will be reported to the co-supervisor (D.M.) and managed through removal of restoration, alleviation of pain and replacement with control restoration.
- Auditing: In the present trial, auditing will be done by the main supervisors and co-supervisors (O.S. and D.M.) to assure quality of the research methods, restorative technique and interventions.
Section IV:
Ethics and dissemination. 24. Research ethics approval: Application forms for carrying out the clinical trial, checklist and informed consent of Research Ethics Committee (REC) Faculty of Dentistry, Cairo University will be retrieved and filled, then will be delivered for REC committee for approval, this is done to prevent any ethical problems during the study or any harm for any of the participants.
- Protocol amendments: If a new protocol will be used a protocol amendment will be submitted; containing a new copy of the new protocol and brief explanation about the differences between it and the previous protocols. If there is a change in the existing protocol that affects safety of subjects, investigation scope or scientific quality of the trial, an amendment containing a brief explanation about the change will be submitted. If a new author will be added to accomplish the study, an amendment including the investigator's data and qualifications to conduct the investigation will be submitted to prevent ghost authorship.
- Consent: Researcher (M.S.) will introduce the trial to patients and provide full explanation of its aim and benefits in plain language. Patients will then be able to have an informed discussion with the researcher. Researcher will obtain written consent from patients willing to participate in the trial. All, consent forms have been translated into Arabic.
- Confidentiality: Name and personal data of the participants will not appear on the protocol form and will be maintained secured for 10 years after the trial. This is done for protection of participants' privacy and civil rights.
- Declaration of interests: There is no conflict of interest, no funding or material supplying from any parties.
- Access to data: Access to final data will be allowed to the operator M.S. and main and co- supervisors (O.S. and D.M.) of the study who are not involved in assessment of the outcome.
- Ancillary and post-trial care: Patients will be followed up after restoration to ensure oral hygiene measures. When there is any evidence of restoration failure, patients will be treated by immediate restoration removal and control restoration placement.
- Dissemination policy:
- Full protocol will be published online in Clinicaltrials.gov to avoid repetition, and keep the integrity of the research work.
- Thesis will be discussed and defended in front of a judgment committee.
- The study will be published to report the results of this clinical trial.
- Conditions
- Dental Caries Class II
- Being tested
- Class II Restoration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Class II RestorationProcedure or surgery
A Class II cavity will be prepared after local anesthesia has been given as required.Rubber dam isolation will be done.Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence.followed by filling of cavity in increments of 3-4mm
| Study group | Role | What they receive |
|---|---|---|
| Self- Adhesive Bulk fill Resin Composite ( Surefil one™ ,Dentsupply Sirona) | Experimental | New Surefil one™ restorative Self-adhesive: no etching, bonding or cavity conditioning inserted in increments of up to 4 mm in thickness. Receives: Procedure: Class II Restoration |
| Bulkfill Resin Composite. (Tetric N-Ceram Bulk Fill ) | Active comparator | after selective etching of enamel and bonding, the bulk-fill composite resins are inserted in increments of up to 4 mm in thickness. Receives: Procedure: Class II Restoration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fracture
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Measured: 18 months
Marginal adaptation
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Measured: 18 months
Anatomic form
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Measured: 18 months
Surface roughness
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Measured: 18 months
Retention
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Measured: 18 months
Secondary outcomes (2)
Postoperative sensitivity
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Measured: 18 months
secondary caries
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Measured: 18 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2021
- Study start15 Jun 2021
- Primary completion15 Dec 2022 (estimated)
- Study completion15 May 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dental Caries Class IIStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Parallel Controlled Trial. Trial type: Two, Parallel arm design. Trial framework: Equivalence frame Allocation ratio: 1:1.
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, mohamed mohamed sabry mohamed, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04888676
- Sponsor's protocol ID
- cons21
- Status last verified
- Oct 2022
- First submitted
- 6 May 2021
- Last updated
- 18 Oct 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: * Full protocol will be published online in Clinicaltrials.gov to avoid repetition, and keep the integrity of the research work. * Thesis will be discussed and defended in front of a judgment committee. * The study will be published to report the results of this clinical trial.
Study at a glance
From the registry record, last updated by the sponsor on 18 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Evaluation of Self- Adhesive Bulk-fill Resin Composite Versus Conventionally Bonded Bulk-fill Resin Composite in Restoration of Proximal Lesions Over a Period of 18 Months Follow-up: A Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT04888676
- Acronym / sponsor ID
- cons21
- Conditions
- Dental Caries Class II
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 15 Jun 2021 (actual)
- Primary completion
- 15 Dec 2022 (estimated)
- Study completion
- 15 May 2023 (estimated)
- First posted
- 17 May 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will be conducted to evaluate and compare the clinical performance of Self- Adhesive Bulk fill Resin Composite Versus Conventionally Bonded Bulk fill resin composite in Restoration of Proximal Lesions Over a Period of 18 months Follow-up
Examination and selection of all patients will be done according to inclusion and exclusion criteria.A Class II cavity will be prepared after local anesthesia has been given as required. Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence,. For the intervention: The sectional matrix will be applied first , followed by filling of cavity with Advanced Self- Adhesive bulk-fill Resin Composite. (Surefil one™ ,Dentsupply Sirona) in increments of 3-4mm,For the control group:
The sectional matrix will be applied first , followed by filling of cavity with bulk-fill resin composite material (GrandioSO x-tra® bulk) in increments of 3-4mm,Clinical evaluation will be done using using USPHS criteria at 6,12 and 18 months follow up.
Detailed description
- Participants, interventions \& outcomes 9. Study setting Study will be conducted in the Conservative Dentistry Department, Faculty of Dentistry - Cairo University.
- Eligibility criteria 10.a.1 Inclusion criteria:
Patient-related criteria:
- Patients consulting in one of the outpatient clinics listed above.
- Able to tolerate necessary restorative procedures.
- Provide informed consent.
- Accepts the 18 months follow-up period.
Tooth related criteria:
- Teeth with primary proximal carious lesions .
- Teeth are vital according to pulp-sensitivity tests. 10.a.2 Exclusion criteria
Patient-related criteria:
- Medically compromised patients, as they will not be able to attend multiple appointments or may require special management.
- Pregnant women; as radiographs cannot be taken for them.
- Allergy to any of the restorative materials, including anesthetics.
- Uncooperative patients, will not abide by the instructions or attend the appointments.
Tooth related criteria:
- Deciduous teeth; as the study is targeting only permanent teeth.
- Teeth with previous restorations, which may add another variable to the study (type of old restorative material, extent of recurrent caries).
- Spontaneous pain or prolonged pain after sensitivity tests (cold and electrical tests), which would indicate irreversible pulpal damage.
- Negative sensitivity tests, periapical radiolucencies and sensitivity to axial or lateral percussion, which would indicate pulp necrosis.
- Teeth presenting external or internal resorption, with adverse pulpal reactions which may affect the outcome of the study.
- Teeth with cervical caries; which can't be evaluated on periapical radiographs. 11. Interventions 11.a. Examination and diagnosis: Examination and selection of all patients will be done according to inclusion and exclusion criteria. Diagnosis of patients' chief complaint and teeth that will be involved in this study will be done. Teeth are to be chosen according to standardized radiographic examination. Teeth should have proximal, primary carious lesions . 11.b. Cavity preparation procedure: A Class II cavity will be prepared after local anesthesia has been given as required. The cavity will be prepared using a high-speed hand-piece with air and water coolant and diamond burs of different sizes. Sharp excavators will allow accessible removal of soft carious lesions will be used. Any tooth that will suffer from pulpal exposure will be excluded from the study. Finishing of the cavity walls will be done using a fine-grit, yellow coded, diamond bur. 11.c. Isolation: Rubber dam isolation will be done. 11.d. Matricing and wedging: Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence. 11.e. For the intervention: The sectional matrix will be applied first , followed by filling of cavity with Advanced Self- Adhesive bulk-fill Resin Composite. (Surefil one™ ,Dentsupply Sirona) in increments of 3-4mm, as required to end up with leaving an occlusal space on top of at least 2mm. Finally finishing and occlusal adjustment will be done under water spray by using superfine diamond burs. Polishing will be done using pre-impregnated rubber cups. Materials will be manipulated according to manufacturer instructions. 11.f. For the control group: The sectional matrix will be applied first , followed by filling of cavity with bulk-fill resin composite material (GrandioSO x-tra® bulk) in increments of 3-4mm, as required to end up with leaving an occlusal space on top of at least 2mm. Finally finishing and occlusal adjustment will be done under water spray by using superfine diamond burs. Polishing will be done using pre-impregnated rubber cups. Materials will be manipulated according to manufacturer instructions. 11.g. Intervention modification: Restoration will be removed when there are any signs of leakage, fracture or severe post-operative pain due to pulpal response. 11.h. Intervention adherence: The patients' understanding of their conditions and treatments, and the amount of information given to the patient is positively related to adherence to the study and instructions given. Thus, the operator (M.S.) will inform the participants about all steps from the beginning to the end and explain the importance of restoring their teeth with such esthetic restorative materials, following instructions, attending follow up visits and how to maintain good oral hygiene. This will be done using simple oral conversation, emphasized by written and illustrated material whenever possible. Oral hygiene of the participants will be enhanced before intervention and any other chief and subsidiary complaint will be managed in order to modify their behavior.
- Outcomes: Clinical evaluation using USPHS criteria. 14. Sample Size : We are planning a study of independent cases and controls. Sample size was calculated based on the previous study by Guney et al in 2020. Prior data indicated that the probability of score A for marginal adaptation for bulk fill composite was 0.861 and score B was 0.139 with effect size w 0.722 (n=16). If the estimated probability of score A for marginal adaptation for self adhesive restorative material is 0.85 and score B is 0.15 with effect size w 0.7 (n=17), we will need to study a total of 33 restorations to be able to reject the null hypothesis that the success rates for case and controls are equal with probability (power) 0.8. This was increased to 40 subjects, 20 in each group to compensate for losses during follow up. The type I error probability associated with this test of this null hypothesis is 0.05. Sample size was calculated using G*Power version 3.1.9.2 for windows using chi-square test 15. Recruitment: Patients will be recruited by the principle investigator (M.S.) from outpatient clinic of conservative dentistry department in Faculty of Dentistry, Cairo University; from which eligible patients will be recruited to fulfill the eligibility criteria according to participant timeline.
- Assignment of interventions 16. Allocation - sequence generation 16.a. Random sequence generation (Randomization): Simple randomization will be assigned for participants by generating numbers from 1:48 using Random Sequence Generator, Randomness and Integrity Services Ltd (https://www.random.org/) by D.K. . Each generated random number will represent assigning both intervention and comparator to each patient in a random manner.
16.b. Allocation concealment mechanism: The restorative technique will be selected according to randomized numbers in a sealed envelope.
16.c. Implementation: Randomization will be performed by D.K. 17. Blinding Double Blinded; The participants Participants will be blinded to the technique used, since the patient will attend the same number of visits and he can not differentiate between different restorative materials.
Blinding of the operator The operator cannot be blinded because of the use of different restorative materials applied in each group.
The outcome assessor The outcome assessor will be blinded to the material used. This will be performed by M.A. and Y.H. Therefore it is necessary that the assessors won't be included in the preclinical assessment.
- Data collection, management and analysis 18. Data collection methods 18.a. Data collection methods: 18.a.i. Baseline data collection: For every patient, medical and dental history will be taken. Examination charts will be filled by M.S.
18.a.ii. Outcome data collection: Modified USPHS criteria for dental restoration will be evaluated by two assessors (M.A \& Y.H) at baseline, after 6 ,12 and 18 months, if both assessors differ in score, they will discuss the outcome, if they did not agree, a third assessor (D.M) will resolve the conflict. To achieve inter-examiners reliability, at the beginning of the study, the assessors will perform a profound assessment training program by performing repeated assessments of 36 proximal surface restorations using modified USHPS criteria. The main supervisor (O.S.) will supervise the training program to ensure that the assessors (M.A \& Y.H.) will be calibrated before starting their evaluation.
18.b. Patient retention: A record of patient's phone number will be included in every patient's chart. Phone call will be diverted to each patient in order to remind him/her for the time of his/her visit (M.S.). If the patient did not reply for any reason, another visit will be scheduled within a week.
- Data management: Data entry will be carried out by M.S. and revised by D.M. . All data will be stored on computer and will be encrypted using a password. This will be done to allow accurate data entry through revision and protect data from being incorrectly used. Data will be backed up on another storage device to prevent it from being lost.
- Statistical methods: Data will be analyzed using IBM SPSS advanced statistics (Statistical Package for Social Sciences), version 25 (SPSS Inc., Chicago, IL).Categorical data will be described as absolute risk for each intervention independently and relative risk when comparing both interventions. Comparisons between categorical variables will be performed using the chi square test. A p-value less than or equal to 0.05 will be considered statistically significant and all tests will be two tailed. Statistical power of the study will be set at 80 % with 95 % confidence level.
- Data monitoring:
- Monitoring: The main supervisor (O.S.) will monitor this study. Her role is to monitor any risk of bias could be done from participants, operator or assessors. Also to monitor blinding of the assessors and patient safety, outstanding benefits or harms.
- Harms: The principle investigator (M.S.) should inform participants about the possible harms (pain, loss of restoration, leakage and fracture of restorations) if present. Participants are allowed to contact the operator at moment through telephone. For assessment radiograph, inspection, percussion and sensitivity tests will be performed. The data will be reported to the co-supervisor (D.M.) and managed through removal of restoration, alleviation of pain and replacement with control restoration.
- Auditing: In the present trial, auditing will be done by the main supervisors and co-supervisors (O.S. and D.M.) to assure quality of the research methods, restorative technique and interventions.
Section IV:
Ethics and dissemination. 24. Research ethics approval: Application forms for carrying out the clinical trial, checklist and informed consent of Research Ethics Committee (REC) Faculty of Dentistry, Cairo University will be retrieved and filled, then will be delivered for REC committee for approval, this is done to prevent any ethical problems during the study or any harm for any of the participants.
- Protocol amendments: If a new protocol will be used a protocol amendment will be submitted; containing a new copy of the new protocol and brief explanation about the differences between it and the previous protocols. If there is a change in the existing protocol that affects safety of subjects, investigation scope or scientific quality of the trial, an amendment containing a brief explanation about the change will be submitted. If a new author will be added to accomplish the study, an amendment including the investigator's data and qualifications to conduct the investigation will be submitted to prevent ghost authorship.
- Consent: Researcher (M.S.) will introduce the trial to patients and provide full explanation of its aim and benefits in plain language. Patients will then be able to have an informed discussion with the researcher. Researcher will obtain written consent from patients willing to participate in the trial. All, consent forms have been translated into Arabic.
- Confidentiality: Name and personal data of the participants will not appear on the protocol form and will be maintained secured for 10 years after the trial. This is done for protection of participants' privacy and civil rights.
- Declaration of interests: There is no conflict of interest, no funding or material supplying from any parties.
- Access to data: Access to final data will be allowed to the operator M.S. and main and co- supervisors (O.S. and D.M.) of the study who are not involved in assessment of the outcome.
- Ancillary and post-trial care: Patients will be followed up after restoration to ensure oral hygiene measures. When there is any evidence of restoration failure, patients will be treated by immediate restoration removal and control restoration placement.
- Dissemination policy:
- Full protocol will be published online in Clinicaltrials.gov to avoid repetition, and keep the integrity of the research work.
- Thesis will be discussed and defended in front of a judgment committee.
- The study will be published to report the results of this clinical trial.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized Parallel Controlled Trial. Trial type: Two, Parallel arm design. Trial framework: Equivalence frame Allocation ratio: 1:1.
| Arm | Type | Receives |
|---|---|---|
| Self- Adhesive Bulk fill Resin Composite ( Surefil one™ ,Dentsupply Sirona) | Experimental | Procedure: Class II RestorationNew Surefil one™ restorative Self-adhesive: no etching, bonding or cavity conditioning inserted in increments of up to 4 mm in thickness. |
| Bulkfill Resin Composite. (Tetric N-Ceram Bulk Fill ) | Active comparator | Procedure: Class II Restorationafter selective etching of enamel and bonding, the bulk-fill composite resins are inserted in increments of up to 4 mm in thickness. |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- -
- Patients consulting in one of the outpatient clinics listed above.
- Able to tolerate necessary restorative procedures.
- Provide informed consent.
- Accepts the 18 months follow-up period.
Key exclusion criteria (12 listed)
- Medically compromised patients, as they will not be able to attend multiple appointments or may require special management.
- Pregnant women; as radiographs cannot be taken for them.
- Allergy to any of the restorative materials, including anesthetics.
- Uncooperative patients, will not abide by the instructions or attend the appointments.
- Deciduous teeth; as the study is targeting only permanent teeth.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Class II RestorationA Class II cavity will be prepared after local anesthesia has been given as required.Rubber dam isolation will be done.Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence.followed by filling of cavity in increments of 3-4mm | Procedure or surgery | Bulkfill Resin Composite. (Tetric N-Ceram Bulk Fill ), Self- Adhesive Bulk fill Resin Composite ( Surefil one™ ,Dentsupply Sirona) |
Primary outcome
Fracture
Time frame: 18 months
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Marginal adaptation
Time frame: 18 months
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Anatomic form
Time frame: 18 months
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Surface roughness
Time frame: 18 months
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
Retention
Time frame: 18 months
The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.
2 secondary outcomes
Postoperative sensitivity
Time frame: 18 months
secondary caries
Time frame: 18 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Oct 2022.
- Individual participant dataSharing planned: Yes. * Full protocol will be published online in Clinicaltrials.gov to avoid repetition, and keep the integrity of the research work. * Thesis will be discussed and defended in front of a judgment committee. * The study will be published to report the results of this clinical trial.
Related trials for Dental Caries Class II
Active, not recruiting
Clinical Evaluation of a New Dual-cure Universal Adhesive
Class I Dental Restorations, Class II Dental Restorations
Not yet recruiting
Clinical Evaluation of Different Bulk-Fill Restorative Materials in Primary Molars
Decayed Primary Molars, Decayed Tooth
Active, not recruiting
Clinical Performance of Different Ion-Releasing Restorative Systems in Class II Cavities
Dental Caries
Active, not recruiting
Bioactive Restorative Materials for Class II Restorations
Bioactive Dental Restorative Materials, Class II Dental Caries
Recruiting
Clinical Performance of Bioactive Bulk-Fill in Class II Restorations
Dental Caries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Class II Restoration in people with Dental Caries Class II, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 18 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fracture (time frame: 18 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2022.